Develops therapies that degrade disease-causing proteins using targeted approaches to enable new treatments for complex conditions.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Plexium develops biotechnology therapies that use targeted protein degradation to treat complex diseases. The company builds a drug discovery platform that identifies small molecules capable of selectively breaking down disease-causing proteins within cells. Its approach enables the development of novel treatments for conditions such as cancer and neurological disorders by targeting previously hard-to-treat proteins.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Plexium Management Team
Investors
AbbVie Ventures
Plexium Valuations & Financials
View real-time NPM data on Plexium stock including daily Plexium stock price estimates, valuation history, and historical share price information. Access Plexium financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Plexium pricing across six independent market signals. Looking for private company due diligence data sources on Plexium? Get in touch to learn more.
Similar Companies
like Plexium
Carallel
Healthcare & Life Sciences
Develops a support platform that guides caregivers with resources, expert assistance, and tools for managing care responsibilities.
Optain Health
Healthcare & Life Sciences
Utilizes AI-enhanced retinal imaging to provide rapid, non-invasive screening for ocular and systemic diseases, facilitating early detection and improved patient outcomes.
Edifice Health
Healthcare & Life Sciences
Delivering an AI-driven inflammation age metric paired with personalized interventions to proactively strengthen immune and systemic health.
NanoImaging
Healthcare & Life Sciences
Delivers high‑resolution imaging for structural insights via integrated cryo‑EM and nanoparticle characterization services.
Cadence
Healthcare & Life Sciences
Remote patient monitoring platform enables healthcare providers to track vitals and manage chronic conditions in real-time.
Enzo Health
Healthcare & Life Sciences
Provides an AI-powered platform purpose-built for home health agencies, unifying front office, clinical, and back-office operations in a single system.
Professional Credentials Exchange
Healthcare & Life Sciences
Offers a platform that securely manages and exchanges verified credentials while streamlining compliance and reducing redundant administrative work.
Ritten
Healthcare & Life Sciences
Delivering that centralizes behavioral health workflows through intuitive automation and customizable clinical tools.
GenoPalate
Healthcare & Life Sciences
Uses DNA insights to recommend tailored dietary and supplement plans.
FAQ
We have answers
Plexium stock does not trade on public stock exchanges. Plexium stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Plexium stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Plexium Stock does not trade on public stock exchanges. In order to sell Plexium shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Plexium does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Plexium share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Plexium stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Plexium stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Plexium stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Plexium is a private company and has not had an IPO. There is currently no Plexium IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Plexium IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
